Shelter Pharma Ltd

Shelter Pharma Other Announcement

Shelter Pharma reports no deviation in use of Rs 2602.50 lakh warrant proceeds. The statement is certified by Alvi & Associates.

Shelter Pharma H1 FY27 Results: Net Profit ₹5.2 Cr, Up 15.6% YoY

Shelter Pharma Ltd reported revenue from operations of ₹45.1 Cr (+35.4% YoY) and net profit of ₹5.2 Cr (+15.6% YoY) for H1 FY27.

Key figure

Net profit ₹5.2 Cr · +15.6% YoY

Shelter Pharma Board Meeting Date

Shelter Pharma intimated its Board meeting is scheduled for November 7, 2026, to approve H1 FY27 unaudited results. Trading window remains closed until November 9, 2026.

Shelter Pharma Bags ₹0.22 Cr Order from First Vet Veterinary Medicines Trading L.L.C

Shelter Pharma won a USD 23,300 (Rs 0.22 Crore) export order from First Vet, UAE. Ordinary course business, executable per the purchase order schedule.

Value

₹0.22 Cr

From

First Vet Veterinary Medicines Trading L.L.C

Execution

Within the mutually agreed timelines as per the purchase order schedule

Shelter Pharma Bags ₹0.1 Cr Order from Genet International

Shelter Pharma won a Rs.0.10 Crore order from Genet International in Bangladesh. It covers 10,000 boxes in the normal course of business.

Value

₹0.10 Cr

From

Genet International

Execution

Within mutually agreed timelines as per the purchase order schedule

Shelter Pharma Bags ₹3.15 Cr Order from Taha Drugs & Chemicals Co. Ltd.

Shelter Pharma Ltd received an international order from Taha Drugs & Chemicals Co. Ltd. worth Rs.3.15 Crore (USD 3,30,975). Execution follows mutually agreed purchase order schedules.

Value

₹3.15 Cr

From

Taha Drugs & Chemicals Co. Ltd.

Execution

Within mutually agreed timelines as per purchase order schedule

Shelter Pharma Bags ₹3.47 Cr Order from Taha Drugs & Chemicals Co. Ltd.; First Vet Veterinary Medicines...

Shelter Pharma received export orders worth Rs. 3.47 Crore from three overseas buyers. Execution follows mutually agreed purchase-order schedules, in the normal course of business.

Value

₹3.47 Cr

From

Taha Drugs & Chemicals Co. Ltd.; First Vet Veterinary Medicines Trading L.L.C; Genet International

Execution

As per mutually agreed purchase order schedules

Shelter Pharma Other Announcement

Shelter Pharma Ltd filed its shareholding pattern under Regulation 31(1)(c). The filing reports promoter, public and category-wise holdings without any transaction.

Shelter Pharma Preferential Issue

Shelter Pharma Ltd has allotted 4,65,000 equity shares via a preferential issue at ₹42.25 per share. This transaction resulted in a total capital infusion of ₹1.96 Crore.

Value

₹1.96 Cr

Shelter Pharma Convertible Warrants

Shelter Pharma Limited approved the conversion of 465,000 warrants into equity shares for its promoter. This allotment follows the receipt of the remaining exercise price of Rs. 1.47 Crore.

Value

₹1.47 Cr

Shelter Pharma Other Announcement

Shelter Pharma Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026. This is a routine regulatory compliance disclosure.

Shelter Pharma Management Change

Shelter Pharma Limited has regularized Ms. Vinita Shivraj Gadhavi as a Non-Executive Independent Director for a five-year term, following approval by shareholders at the 19th AGM.

Shelter Pharma Annual General Meeting

Shelter Pharma Limited conducted its 19th Annual General Meeting on September 29, 2026. Key agenda items included adopting financial statements and ratifying material related party transactions.

Shelter Pharma Bags ₹0.1 Cr Order from Berlin International Company

Shelter Pharma received a ₹0.10 Cr export order from Berlin International Company for D3 CURE nutraceuticals. The order broadens its global nutraceutical customer base.

Value

₹0.10 Cr

From

Berlin International Company

Execution

mutually agreed timelines as per purchase order schedule

Shelter Pharma Business Update

Shelter Pharma will participate in the Vishwa Ayurveda Parishad Exhibition in Jaipur on 17-18 September 2026. The company secured a stall to showcase its pharmaceutical and Ayurveda product portfolio.

Shelter Pharma Annual Report

Shelter Pharma Ltd has filed its 19th Annual Report for the financial year 2025-26 in compliance with SEBI (LODR) regulations.

Shelter Pharma Annual General Meeting

Shelter Pharma Limited announced its 19th Annual General Meeting for September 29, 2026. The board also approved the regularisation of Ms. Vinita Shivraj Gadhvi as Independent Director.

Shelter Pharma Management Change

Shelter Pharma Limited announced the regularization of Ms. Vinita Shivraj Gadhavi as a Non-Executive Independent Director. The Board also approved the notice for the 19th AGM.

Shelter Pharma Business Update

Shelter Pharma Limited completed and dispatched a nutraceutical export order worth USD 139,200 to Sudan. The client is Taha Drugs & Chemicals Co. Ltd.

Value

₹1.32 Cr

Shelter Pharma Business Update

Shelter Pharma Limited has successfully completed and dispatched an export order to Sudan. The contract, from Taha Drugs & Chemicals Co. Ltd, is valued at $1,44,000.

Value

₹1.37 Cr

Shelter Pharma Product Launch

Shelter Pharma Limited launched SHELTIDIN DS, an Ayurvedic herbal cough spray, in the domestic market. The product is available on e-commerce platforms as of August 20, 2026.

Shelter Pharma Business Update

Shelter Pharma Limited successfully completed and dispatched an export order worth USD 12,285 to Genet International in Bangladesh. This marks a milestone in the company's international growth.

Value

₹0.12 Cr